Scientists associated with Madras Diabetes Research Foundation (MDRF) find that it often presents with more severe beta-cell dysfunction and relatively less insulin resistance.
The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady entry into a market once dominated by Big pharma.
Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, received CDSCO approval this week.
Novo Nordisk scientists have synthesised an insulin molecule that specifically targets glucose in blood, instead of other sugars like fructose, to aid treatment of all types of diabetes.
Doctors Without Borders says new class of drugs & insulin devices could be leading to ‘exorbitant corporate profiteering’. Study published in Journal of the American Medical Association.
Icodec has been touted as a therapy that could eliminate the need for daily or mealtime insulin injections for people with severe diabetes. It has not been approved by any country so far.
Danish pharmaceutical giant Novo Nordisk has said it is set to apply for regulatory approval of its once-a-week insulin drug, Icodec. Results of Phase-3 clinical trial shown 'promising results'.
UK patients may soon be covered for the device, which measures blood glucose, computes amount of insulin needed and then pumps that exact amount into bloodstream.
Indian refiners had been importing roughly 1 mbpd of Russian crude in the recent months, and the waiver will effectively allow them to lift volumes above this baseline.
Two Indian naval ships involved in the search and rescue operations in connection with IRIS Dena, which was operating 20 NM West of Galle in SAR region under Sri Lankan responsibility.
The Pakistani political leadership is weak and devoid of any intellect. Its diplomacy is entirely India-China-US focused and suffers from a presumptive view of Afghanistan as a vassal.
COMMENTS